No Data
No Data
Gelonghui Announcements Selected | HuaTest Navigation: The actual controller's concerted actions plan to increase the company's shares by 120 million yuan to 200 million yuan; Hanshang Group: Currently not developing stem cell treatment business
[Hot Focus] Hanshang Group (600774.SH): Currently not operating stem cell treatment business Hanshang Group (600774.SH) announced abnormal stock trading fluctuations, and the company is not currently engaged in stem cell treatment business. The company's Wuhan Huake Reproductive Specialist Hospital was awarded the “Hubei Engineering Research Center for Human Stem Cell Preparation and Application and Resource Preservation”. Currently, it is in the early stages of research and development, and no clinical application has been carried out. There have been no major changes in the company's main business, and there have been no major changes in fundamentals. Xinghu Technology (600866.SH): Shareholders Yipin Group and Tie Xiaorong reduced their total holdings
Yike Food (301116.SZ): Signed an investment framework agreement with the Suqian High-tech Zone Management Committee
Gelonghui, May 9丨Yike Food (301116.SZ) announced that it signed an “Investment Framework Agreement” with the Suqian High-tech Industrial Development Zone Management Committee (“High-tech Zone Management Committee”). Based on the principles of honesty, trustworthiness, equality and mutual benefit, after friendly negotiations between the two parties, the company invested in the construction of the Suyu Yike headquarters and the whole industry chain project in Suyu District of Suqian City. Through the construction of the new project, it formed integrated breeding (chicken breeding, duck breeding) breeding technology and services Material development and production, poultry slaughter and processing, prepared products, cooked food Commercial chains, down processing,
Yike Foods (301116.SZ) announced first-quarter results, net profit of 784.387 million yuan, a year-on-year decrease of 32.97%
According to Zhitong Finance App, Yike Food (301116.SZ) released its report for the first quarter of 2024. The company achieved operating income of 4.589 billion yuan, a year-on-year decrease of 11.08%; net profit attributable to shareholders of listed companies was 784.387 million yuan, a year-on-year decrease of 32.97%; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 754,048 million yuan, a year-on-year decrease of 33.78%; basic earnings per share were 0.1,751 yuan/share.
Are Jiangsu Yike Food Group Co.,Ltd's (SZSE:301116) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?
Jiangsu Yike Food GroupLtd (SZSE:301116) has had a rough three months with its share price down 28%. It seems that the market might have completely ignored the positive aspects of the company's fund
Yike Food (301116.SZ): Products cover core market regions such as Beijing-Tianjin-Hebei, Yangtze River Delta, and Pearl River Delta
Gelonghui, April 11 | Yike Food (301116.SZ) said on the investor interactive platform that the company's products span core market regions such as Beijing-Tianjin-Hebei, Yangtze River Delta, and Pearl River Delta, and have not yet been directly launched in Hong Kong and Macau.
Yike Food (301116.SZ): Shuyang Zhongke Breeding Poultry obtained a supporting system certificate from the National Livestock and Poultry Genetic Resources Commission
Gelonghui, March 13, 丨 Yike Food (301116.SZ) announced that the company recently received a notice from its wholly-owned subsidiary Shuyang Zhongke Poultry Breeding Co., Ltd. (“Shuyang Zhongke Breeding Poultry”) that the Yiyang No. 1 meat duck support line has been approved by the National Livestock and Poultry Genetic Resources Commission, and the National Livestock and Poultry Genetic Resources Assessment Measures have issued supporting system certificates in accordance with the “Measures for New Livestock and Poultry Breeding Systems” and other relevant regulations.
No Data